SI-BONE Q4 2024 revenue $49M (+26% YoY); positive adjusted EBITDA; 2025 revenue guidance ~$194M

SI-BONE, Inc.

2024-FY EPS reported -$0.75 revenue$167,178,000

Q4 revenue $49.0M, up 26% YoY; U.S. revenue $46.9M (+28%); gross margin ~79%.
Net loss improved ~59% to $4.5M ($0.11/diluted share) from $11.0M loss in Q4 2023.
Q4 adjusted EBITDA positive $1.9M, a ~139% improvement from -$4.8M prior year.
FY2024 revenue $167.2M (+20% YoY); net loss $30.9M, improved ~29% from $43.3M.
FY2025 revenue guidance $193.5-$195.5M (~16-17% growth); expects positive adjusted EBITDA for full year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.